Resource Utility {#S2}
================

Pathological myopia (PM) is a major cause of irreversible vision impairment worldwide. A lack of elaborated etiology and suitable animal models makes it an incurable disease. The FDEENTi003-A iPSC line may serve as a useful tool to explore the pathogenesis of PM.

Resource Details {#S3}
================

Pathological myopia (PM) is a major cause of irreversible vision impairment and blindness worldwide, especially in Asia. It refers to highly myopic eyes with characteristic chorioretinal atrophy, which often leads to progressive and irreversible vision loss ([@R3]). Pathogenesis of PM is complex and still unclear, partly due to the limited access to patients' atrophic retina tissues and a lack of animal models to recapitulate the disease phenotypes.

To provide a source of patient retinal tissue of PM for study, we generated a patient-derived PM-specific induced pluripotent stem cell (iPSC) line and differentiated it into retinal pigment epithelium (RPE), one of the ten layers of retina. A 55-year-old female patient presented with high myopia accompanied by characteristic chorioretinal atrophy in both eyes. Peripheral blood was collected and freshly isolated for mononuclear cells. The cells were reprogrammed by Sendai viral vectors expressing OCT4, SOX2, KLF4 and C-MYC([@R1]). The established FDEENTi003-A line exhibited a typical morphology of human embryonic stem cell (hESC) colonies ([Fig. 1A](#F1){ref-type="fig"}, [Table 1](#T1){ref-type="table"}) and was positive for alkaline phosphatase staining ([Fig. 1B](#F1){ref-type="fig"}). The expression of major pluripotent markers was examined by immunocytochemical staining using antibodies against human OCT4, SOX2, NANOG ([Fig. 1G](#F1){ref-type="fig"}). Quantitative polymerase chain reaction (qPCR) showed that OCT4, SOX2 and NANOG mRNA was expressed at similar levels between FDEENTi003-A iPSC and hESC and was hardly expressed /absent in the parental PBMCs ([Fig. 1C](#F1){ref-type="fig"}). The FDEENTi003-A line showed a normal diploid 46, XX karyotype (at passage 10) ([Fig. 1D](#F1){ref-type="fig"}) and was genetically authenticated with the patient's peripheral blood cells by short tandem repeat (STR) analysis. SeV genome and transgenes were absent at passage 11 as confirmed by RT-PCR ([Fig. 1E](#F1){ref-type="fig"}). PCR testing demonstrated the absence of mycoplasma contamination ([Fig. 1F](#F1){ref-type="fig"}). Trilineage differentiation potential was detected in vitro and confirmed by the expression of ectoderm (PAX6), mesoderm (MESP1), and endoderm (FOXA2) markers ([Fig. 1H](#F1){ref-type="fig"}). Furthermore, the potential for differentiation into retina was confirmed by directed differentiation into RPE, one of the ten layers of human retina. Patient-derived iPSC-RPE exhibited a typical polygonal morphology similar to that of human RPE cells, pigmented, and expressed major RPE markers (ZO-1, BEST1, MITF). ([Fig. 1](#F1){ref-type="fig"}).

Materials and methods {#S4}
=====================

Cell culture and reprogramming {#S5}
------------------------------

PBMCs were isolated from the whole blood sample using Histopaque^®^−1077 (Sigma-Aldrich) and cultured in StemSpan SFEMIImedium (Stem Cell Technologies) supplemented with 100 ng/ mL SCF, 100 ng/mL FLT-3 L, 20 ng/mL IL-3 and 20 ng/mL IL-6 cytokines (Peprotech). Five days later, the cells were collected and transduced with CytoTune^®^-iPS 2.0 Sendai reprogramming vectors (Thermo Fisher) following the manufacturer's instruction. The transduced cells were plated onto irradiated mouse embryonic fibroblasts (MEFs) and maintained in mTeSR™1 medium (Stem Cell Technologies) which was changed every other day. Around day16 post-transduction, ESC-like colonies appeared and were manually picked on day20 post-transduction. The established iPSCs were cultured on Matrigel (Corning)-coated plates in mTeSR™1 medium at 37 °C with 5% CO~2~ and routinely passaged at 1:3 ratio using dispase (Stem Cell Technologies) every 4--6 days. The iPSCs were frozen in CryoStor^®^ CS10 freezing medium and thawed with 10 μM Y-27632 (Stem Cell Technologies). hESC (H7 \[Wi Cell Research Institute, Madison, WI, USA\]) was cultured in parallel with FDEENTi003-A.

Alkaline phosphatase (AP) staining {#S6}
----------------------------------

Cells were fixed in 4% PFA for 1--2 min and stained for alkaline phosphatase according to Alkaline Phosphatase Detection Kit protocol (Innovative Cellular Therapeutics, China).

Immunocytochemistry {#S7}
-------------------

Cells were fixed in 4% paraformaldehyde for 10 min, permeabilized with 0.2% Triton X-100 for 15 min, and blocked in 4% bovine serum albumin for 30 min at room temperature. Afterwards, they were incubated with primary antibodies at 4 °C overnight and visualized with secondary antibodies for 1 h at room temperature. Both primary and secondary antibodies were diluted in PBS with 1% bovine serum albumin. Nuclei were stained with Hoechst (Thermo Fisher) for 5 min at room temperature. Images were taken by inverted fluorescence microscope (Leica Microsystems, Germany). Antibodies used are listed in [Table 2](#T2){ref-type="table"}.

IPSC differentiation {#S8}
--------------------

For trilineage differentiation, iPSCs were cultured to approximately 70% confluency. Then they were harvested using ACCUTASE™ (Stem Cell Technologies) and plated for trilineage differentiation according to the STEMdiff™ Trilineage Differentiation Kit protocol (Stem Cell Technologies). Five or seven days later, the cells were fixed in 4% paraformaldehyde for assessing lineage specific markers by immunocytochemistry.

For directed differentiation into RPE cells, we followed a previously published protocol ([@R2]). After differentiation and maturation for 3 months, iPSC-RPE were tested for morphology and pigmentation and immunostained for RPE markers.

RT-PCR and qPCR analysis {#S9}
------------------------

Total RNA was extracted using TRIzol® Reagent (Thermo Fisher). 500 ng RNA was reverse transcribed into cDNA using PrimeScript™ RT Master Mix (Takara). RT-PCR was performed on the S1000 Thermal Cycler (BIO-RAD) using EasyTaq® PCR SuperMix (Transgen, China) and analyzed by agarose gel electrophoresis. The cycle parameters were as follows: 95 °C for 5 min followed by 35 cycles of 95 °C for 30 s, 55 °C for 30 s, and 72 °C for 30 s. qPCR was conducted on ViiA™ 7 Real-Time PCR System (Applied Biosystems) and analyzed using the ΔΔCT method. Primers used are listed in [Table 2](#T2){ref-type="table"}.

Karyotyping {#S10}
-----------

FDEENTi003-A cells in the logarithmic phase at passage 10 were treated with colchicine for 4 h and then dissociated into single cells using Accutase(Stem Cell Technologies). The standard G-banding karyotyping was performed by KingMed Diagnostics, Shanghai and 20 metaphase spreads were counted.

Short tandem repeat (STR) analysis {#S11}
----------------------------------

gDNA was isolated using a commercial kit from CORNING (AP-EMN-BL-GDNA-250G). STR analysis was performed on the PBMCs and established iPSCs with detection of 20 loci (D3S1358, D8S1179, D19S433, AMEL, VWA, D21S11, TH01, D5S818, D7S820, D16S539, D13S317, D12S391, CSF1PO, D2S1338, TPOX, FGA, PENTAE, PENTAD, D18S51, D6S1043, D1S1656) by Shanghai Biowing Applied Biotechnology Co, LTD, China.

Mycoplasma test {#S12}
---------------

The absence of mycoplasma was confirmed by EZ-PCR Mycoplasma Test Kit (Biological Industries, BI) following the manufacturer's instruction.
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###### 

Characterization and validation.

  Classification                        Test                                        Result                                                                                         Data
  ------------------------------------- ------------------------------------------- ---------------------------------------------------------------------------------------------- ---------------------------------------
  Morphology                            Photography                                 Normal                                                                                         [Fig. 1](#F1){ref-type="fig"} panel A
  Phenotype                             Qualitative analysis: Immunocytochemistry   Positive for pluripotency markers: OCT4, SOX2, NANOG                                           [Fig. 1](#F1){ref-type="fig"} panel G
                                        Quantitative analysis: RT-qPCR              Positive for pluripotency markers: OCT4, SOX2, NANOG                                           [Fig. 1](#F1){ref-type="fig"} panel C
  Genotype                              Karyotype (G-banding) and resolution        46XX, Resolution 400                                                                           [Fig. 1](#F1){ref-type="fig"} panel D
  Identity                              Microsatellite PCR (mPCR) OR                N/A                                                                                            N/A
                                        STR analysis                                21 loci tested, 100% matched                                                                   Available with authors.
  Mutation analysis (IF APPLICABLE)     Sequencing                                  Not performed                                                                                  N/A
                                        Southern Blot OR WGS                        Not performed                                                                                  N/A
  Microbiology and virology             Mycoplasma                                  Mycoplasma testing by RT-PCR: Negative                                                         [Fig. 1](#F1){ref-type="fig"} panel F
  Differentiation potential             Directed differentiation                    Proof of three germ layers formation: ectoderm (PAX6), mesoderm (MESP1) and endoderm (FOXA2)   [Fig. 1](#F1){ref-type="fig"} panel H
  Donor screening (OPTIONAL)            HIV 1 + 2 Hepatitis B, Hepatitis C          Not performed                                                                                  N/A
  Genotype additional info (OPTIONAL)   Blood group genotyping                      Not performed                                                                                  N/A
                                        HLA tissue typing                           Not performed                                                                                  N/A

###### 

Reagents details.

  -------------------------------------------------------- ------------------------------------ ---------- -----------------------------------------------------------------------------------------------------------------
  Antibodies used for immunocytochemistry/flow-citometry                                                   
                                                                                                           
                                                           Antibody                             Dilution   Company Cat \# and RRID
                                                                                                           
  Pluripotency Markers                                     Rabbit anti-OCT4                     1:200      Abcam Cat\# ab181557, RRID: [AB_2687916](https://AB_2687916)
  Pluripotency Markers                                     Rabbit anti-SOX2                     1:200      Abcam Cat\# ab92494, RRID: [AB_10585428](https://AB_10585428)
  Pluripotency Markers                                     Rabbit anti-NANOG                    1:100      Abcam Cat\# ab21624, RRID: [AB_446437](https://AB_446437)
  Differentiation Markers                                  Rabbit anti-PAX6                     1:200      Abcam Cat\# ab195045, RRID: [AB_2750924](https://AB_2750924)
  Differentiation Markers                                  Mouse anti-MESP1                     1:200      Abcam Cat\# ab77013, RRID: [AB_1566419](https://AB_1566419)
  Differentiation Markers                                  Rabbit anti-FOXA2                    1:200      Abcam Cat\# ab108422, RRID: [AB_11157157](https://AB_11157157)
  RPE Markers                                              Rabbit anti-ZO-1                     1:100      Thermo Fisher Scientific Cat\# 402200, RRID: [AB_2533456](https://antibodyregistry.org/search.php?q=AB_2533456)
  RPE Markers                                              Mouse anti-BEST1                     1:100      Abcam Cat\# ab2182, RRID: [AB_302880](https://AB_302880)
  RPE Markers                                              Mouse anti-MITF                      1:100      Abcam Cat\# ab3201, RRID: [AB_303601](https://AB_303601)
  Secondary antibodies                                     AlexaFlour488 goat anti-mouse IgG    1:1000     Thermo Fisher Scientific Cat\# A-11001, RRID: [AB_2534069](AB_2534069)
  Secondary antibodies                                     AlexaFlour488 goat anti-rabbit IgG   1:1000     Thermo Fisher Scientific Cat\# A-11008, RRID: [AB_143165](https://AB_143165)
  Secondary antibodies                                     AlexaFlour555 goat anti-mouse IgG    1:1000     Thermo Fisher Scientific Cat\#A-21422, RRID: [AB_2535844](https://AB_2535844)
  -------------------------------------------------------- ------------------------------------ ---------- -----------------------------------------------------------------------------------------------------------------

  ------------------------------ ---------------- ------------------------------------------------------
  Primers                                         
                                                  
                                 Target           Forward/Reverse primer (5′−3′)
                                                  
  Sendai viral vector (RT-PCR)   SeV/181 bp       GGATCACTAGGTGATATCGAGC/ACCAGACAAGAGTTTAAGAGATATGTATC
                                 KOS/528 bp       ATGCACCGCTACGACGTGAGCGC/ACCTTGACAATCCTGATGTGG
                                 KLF4/410 bp      TTCCTGCATGCCAGAGGAGCCC/AATGTATCGAAGGTGCTCAA
                                 C-MYC/532 bp     TAACTGACTAGCAGGCTTGTCG/TCCACATACAGTCCTGGATGATGATG
  Pluripotency Markers (qPCR)    OCT4/169 bp      GCAAAGCAGAAACCCTCGTG/CACACTCGGACCACATCCTT
                                 SOX2/171 bp      ATGGACAGTTACGCGCACAT/CGAGCTGGTCATGGAGTTGT
                                 NANOG/179 bp     ACCCAGCTGTGTGTACTCAA/CCATTGCTATTCTTCGGCCA
  House-Keeping Genes (qPCR)     β-ACTIN/110 bp   ACTCTTCCAGCCTTCCTTCC/TGTTGGCGTACAGGTCTTTG
  ------------------------------ ---------------- ------------------------------------------------------

###### 

Resource Table

  --------------------------------------- ----------------------------------------------------------------------------------------------------------------
  Unique stem cell line identifier        FDEENTi003-A
  Alternative name(s) of stem cell line   ZSY-IPS
  Institution                             Eye & ENT Hospital, Shanghai Medical School, Fudan University, Shanghai, China
  Contact information of distributor      Xinyue Bai, [xinyue_bai\@126.com](https://xinyue_bai@126.com)
                                          Ling Chen, [linglingchen98\@hotmail.com](https://linglingchen98@hotmail.com)
  Type of cell line                       iPSC
  Origin                                  Human
  Additional origin info                  Age: 55
                                          Sex: female
                                          Ethnicity: Han Chinese
  Cell Source                             Peripheral blood mononuclear cells (PBMCs)
  Clonality                               Clonal
  Method of reprogramming                 Transgene free, Sendai viral vectors
  Genetic Modification                    NO
  Type of Modification                    N/A
  Associated disease                      Pathological myopia
  Gene/locus                              N/A
  Method of modification                  N/A
  Name of transgene or resistance         N/A
  Inducible/constitutive system           N/A
  Date archived/stock date                1st October 2018
  Cell line repository/bank               <https://hpscreg.eu/cell-line/FDEENTi003-A>
  Ethical approval                        This study was approved by the ethics committee of Fudan University affiliated Eye & ENT Hospital (KJ2011-04).
  --------------------------------------- ----------------------------------------------------------------------------------------------------------------
